Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erasmus Smit

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
American Journal of Clinical Pathology|May 3, 2025
Quantitative EBV detection from whole blood on the COBAS 6800 system in response to Song J, Kim S, Kwak E, Park Y. Applicability of the cobas 6800 System for Epstein-Barr viral load quantitation using whole-blood specimens. Am J Clin Pathol. 2024 Mar 1;161(3):273-282. doi: 10.1093/ajcp/aqad146. PMID: 37936258Radhika Nagappan, Sarah Sarah, Saed Miri Nargesi, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 17, 2019
Human Herpes-8 virus copy to cell ratio: A diagnostic tool in primary effusion lymphomaSimon Carne, Erasmus Smit, Nicola Price, et al.
The Journal of Infectious Diseases|November 26, 2013
Indigenous hepatitis E in England and wales from 2003 to 2012: evidence of an emerging novel phylotype of virusesSamreen Ijaz, Bengü Said, Elizabeth Boxall, et al.
AIDS (London, England)|June 4, 2008
Raltegravir treatment response in an HIV-2 infected patient: a case reportNigel Garrett, Li Xu, Erasmus Smit, et al.
The New Zealand Medical Journal|December 2, 2021
Sensitivity and potential utility of SARS-CoV-2 rapid antigen and nucleic acid amplification tests in the context of an elimination approachJenna Beaumont, Mirsaed Miri Nargesi, Susan Smith, et al.
Antiviral Research|March 10, 2010
Clinical outcome in resistant HIV-2 infection treated with raltegravir and maravirocDarius Armstrong-James, Justin Stebbing, Andrew Scourfield, et al.
The New England Journal of Medicine|November 3, 2016
HIV-Positive-to-HIV-Positive Liver TransplantationEmma Hathorn, Erasmus Smit, Ahmed M Elsharkawy, et al.
Antiviral Therapy|May 9, 2013
Second-line protease inhibitor-based antiretroviral therapy after non-nucleoside reverse transcriptase inhibitor failure: the effect of a nucleoside backboneLaura Waters, Loveleen Bansi, David Asboe, et al.
AIDS Research and Human Retroviruses|July 22, 2009
Dynamics of raltegravir resistance profile in an HIV type 2-infected patientLi Xu, Jane Anderson, Nigel Garrett, et al.
International Journal of Molecular Sciences|March 13, 2025
Optimization and Benchmarking of RT-LAMP-CRISPR-Cas12a for the Detection of SARS-CoV-2 in SalivaCourtney R H Lynch, Revel S M Drummond, Lauren Jelley, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
American Journal of Clinical Pathology|May 3, 2025
Quantitative EBV detection from whole blood on the COBAS 6800 system in response to Song J, Kim S, Kwak E, Park Y. Applicability of the cobas 6800 System for Epstein-Barr viral load quantitation using whole-blood specimens. Am J Clin Pathol. 2024 Mar 1;161(3):273-282. doi: 10.1093/ajcp/aqad146. PMID: 37936258Radhika Nagappan, Sarah Sarah, Saed Miri Nargesi, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 17, 2019
Human Herpes-8 virus copy to cell ratio: A diagnostic tool in primary effusion lymphomaSimon Carne, Erasmus Smit, Nicola Price, et al.
The Journal of Infectious Diseases|November 26, 2013
Indigenous hepatitis E in England and wales from 2003 to 2012: evidence of an emerging novel phylotype of virusesSamreen Ijaz, Bengü Said, Elizabeth Boxall, et al.
AIDS (London, England)|June 4, 2008
Raltegravir treatment response in an HIV-2 infected patient: a case reportNigel Garrett, Li Xu, Erasmus Smit, et al.
The New Zealand Medical Journal|December 2, 2021
Sensitivity and potential utility of SARS-CoV-2 rapid antigen and nucleic acid amplification tests in the context of an elimination approachJenna Beaumont, Mirsaed Miri Nargesi, Susan Smith, et al.
Antiviral Research|March 10, 2010
Clinical outcome in resistant HIV-2 infection treated with raltegravir and maravirocDarius Armstrong-James, Justin Stebbing, Andrew Scourfield, et al.
The New England Journal of Medicine|November 3, 2016
HIV-Positive-to-HIV-Positive Liver TransplantationEmma Hathorn, Erasmus Smit, Ahmed M Elsharkawy, et al.
Antiviral Therapy|May 9, 2013
Second-line protease inhibitor-based antiretroviral therapy after non-nucleoside reverse transcriptase inhibitor failure: the effect of a nucleoside backboneLaura Waters, Loveleen Bansi, David Asboe, et al.
AIDS Research and Human Retroviruses|July 22, 2009
Dynamics of raltegravir resistance profile in an HIV type 2-infected patientLi Xu, Jane Anderson, Nigel Garrett, et al.
International Journal of Molecular Sciences|March 13, 2025
Optimization and Benchmarking of RT-LAMP-CRISPR-Cas12a for the Detection of SARS-CoV-2 in SalivaCourtney R H Lynch, Revel S M Drummond, Lauren Jelley, et al.
Pageof 5